Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117273) titled 'Memantine fOr Social cognition Augmentation In Clinical schizophrenia' on Sept. 9.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:An Open list of random numbers Blinding and masking:Investigator Blinded
Primary Sponsor: Dr Ankita Kaintura
Condition:
Health Condition 1: F20- Schizophrenia
Intervention:
Intervention1: Standard treatment with oral Memantine for 12weeks: Memantine acts as a non-competitive, moderate-affinity, voltage-dependent N-methyl-D-aspartate (N...